These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25445526)

  • 21. In vitro methods to assess drug precipitation.
    Dai WG
    Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
    Ranta VP; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres.
    Lochmann A; Nitzsche H; von Einem S; Schwarz E; Mäder K
    J Control Release; 2010 Oct; 147(1):92-100. PubMed ID: 20603166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems.
    Jug M; Hafner A; Lovrić J; Kregar ML; Pepić I; Vanić Ž; Cetina-Čižmek B; Filipović-Grčić J
    J Pharm Biomed Anal; 2018 Jan; 147():350-366. PubMed ID: 28720350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A drug delivery system based on alginate microspheres: mass-transport test and in vitro validation.
    Ciofani G; Raffa V; Menciassi A; Micera S; Dario P
    Biomed Microdevices; 2007 Jun; 9(3):395-403. PubMed ID: 17252208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology.
    Nayak AK; Pal D
    Int J Biol Macromol; 2011 Nov; 49(4):784-93. PubMed ID: 21816168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.
    Willmann S; Thelen K; Lippert J
    J Pharm Pharmacol; 2012 Jul; 64(7):997-1007. PubMed ID: 22686345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc-alginate microparticles for controlled pulmonary delivery of proteins prepared by spray-drying.
    Möbus K; Siepmann J; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):121-30. PubMed ID: 22342605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
    Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
    J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic considerations for targeted drug delivery.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2013 Jan; 65(1):139-47. PubMed ID: 23280371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the Assessment of Drug Supersaturation and Precipitation In Vitro Using Lipid-Based Delivery Systems.
    Stillhart C; Kuentz M
    J Pharm Sci; 2016 Sep; 105(9):2468-2476. PubMed ID: 26935881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential delivery of TAT-HSP27 and VEGF using microsphere/hydrogel hybrid systems for therapeutic angiogenesis.
    Shin SH; Lee J; Lim KS; Rhim T; Lee SK; Kim YH; Lee KY
    J Control Release; 2013 Feb; 166(1):38-45. PubMed ID: 23262200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation.
    Schweizer D; Vostiar I; Heier A; Serno T; Schoenhammer K; Jahn M; Jones S; Piequet A; Beerli C; Gram H; Goepferich A
    J Control Release; 2013 Dec; 172(3):975-82. PubMed ID: 24140353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties and active substance release kinetics from gelatin-alginate matrices.
    Pluta J; Haznar D
    Polim Med; 2006; 36(3):55-69. PubMed ID: 17190292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bionanocomposites containing magnetic graphite as potential systems for drug delivery.
    Ribeiro LN; Alcântara AC; Darder M; Aranda P; Herrmann PS; Araújo-Moreira FM; García-Hernández M; Ruiz-Hitzky E
    Int J Pharm; 2014 Dec; 477(1-2):553-63. PubMed ID: 25455784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.